Drug-loaded erythrocytes: on the road toward marketing approval
Erythrocyte drug encapsulation is one of the most promising therapeutic alternative approaches for the administration of toxic or rapidly cleared drugs. Drug-loaded erythrocytes can operate through one of the three main mechanisms of action: extension of circulation half-life (bioreactor), slow drug...
Main Authors: | Bourgeaux, Vanessa, Lanao, José M, Bax, Bridget E, Godfrin, Yann |
---|---|
Format: | Online |
Language: | English |
Published: |
Dove Medical Press
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4755692/ |
Similar Items
-
Repurposing of approved cardiovascular drugs
by: Ishida, Junichi, et al.
Published: (2016) -
Approved Essential Drugs For Nepal
by: No Author
Published: (2003-01-01) -
Was there a regulatory approval market for mortgages?
by: Peggy, Crawford, et al.
Published: (2015) -
Marketing approval of mogamulizumab: A triumph for glyco-engineering
by: Beck, Alain, et al.
Published: (2012) -
Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning
by: Kaiser, Marcel, et al.
Published: (2015)